Loading
Latest filing published 05 Feb 2025 for Arcadia Biosciences, Inc., €1,701.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Mark Kawakami in Arcadia Biosciences, Inc. Over a trading history stretching from 1 August 2024 to 3 February 2025, the count stands at 2 filings.
On the market, this insider has only ever bought: 2 purchases, €3,038 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and no sales.
The record was last updated on 5 February 2025 with an open-market purchase (€1,701) in Arcadia Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 1 declaration